Covariate-adjusted borrowing of historical control data in randomized clinical trials

被引:35
作者
Han, Baoguang [1 ]
Zhan, Jia [2 ]
Zhong, Z. John [1 ]
Liu, Dawei [1 ]
Lindborg, Stacy [1 ]
机构
[1] Biogen, Cambridge, MA USA
[2] Indiana Univ Sch Med, Dept Biostat, Fairbank Sch Publ Hlth, Indianapolis, IN 46202 USA
关键词
ALS; Bayesian methods; covariate; hierarchical model; historical control; AMYOTROPHIC-LATERAL-SCLEROSIS; GENERALIZED LINEAR-MODELS; POWER PRIOR DISTRIBUTIONS; COMMENSURATE PRIORS;
D O I
10.1002/pst.1815
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The borrowing of historical control data can be an efficient way to improve the treatment effect estimate of the current control group in a randomized clinical trial. When the historical and current control data are consistent, the borrowing of historical data can increase power and reduce Type I error rate. However, when these 2 sources of data are inconsistent, it may result in a combination of biased estimates, reduced power, and inflation of Type I error rate. In some situations, inconsistency between historical and current control data may be caused by a systematic variation in the measured baseline prognostic factors, which can be appropriately addressed through statistical modeling. In this paper, we propose a Bayesian hierarchical model that can incorporate patient-level baseline covariates to enhance the appropriateness of the exchangeability assumption between current and historical control data. The performance of the proposed method is shown through simulation studies, and its application to a clinical trial design for amyotrophic lateral sclerosis is described. The proposed method is developed for scenarios involving multiple imbalanced prognostic factors and thus has meaningful implications for clinical trials evaluating new treatments for heterogeneous diseases such as amyotrophic lateral sclerosis.
引用
收藏
页码:296 / 308
页数:13
相关论文
共 36 条
[1]  
[Anonymous], 2004, BAYESIAN APPROACHES
[2]  
[Anonymous], 2012, BUGS BOOK PRACTICAL
[3]  
Berry James D, 2011, Clin Investig (Lond), V1, P1375
[4]  
Berry SM, 2010, CH CRC BIOSTAT SER, P1, DOI 10.1201/EBK1439825488
[5]   Power prior distributions for generalized linear models [J].
Chen, MH ;
Ibrahim, JG ;
Shao, QM .
JOURNAL OF STATISTICAL PLANNING AND INFERENCE, 2000, 84 (1-2) :121-137
[6]   The Relationship Between the Power Prior and Hierarchical Models [J].
Chen, Ming-Hui ;
Ibrahim, Joseph G. .
BAYESIAN ANALYSIS, 2006, 1 (03) :551-574
[7]   Prognostic factors in ALS: A critical review [J].
Chio, Adriano ;
Logroscino, Giancarlo ;
Hardiman, Orla ;
Swingler, Robert ;
Mitchell, Douglas ;
Beghi, Ettore ;
Traynor, Bryan G. .
AMYOTROPHIC LATERAL SCLEROSIS, 2009, 10 (5-6) :310-323
[8]   Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial [J].
Cudkowicz, Merit E. ;
van den Berg, Leonard H. ;
Shefner, Jeremy M. ;
Mitsumoto, Hiroshi ;
Mora, Jesus S. ;
Ludolph, Albert ;
Hardiman, Orla ;
Bozik, Michael E. ;
Ingersoll, Evan W. ;
Archibald, Donald ;
Meyers, Adam L. ;
Dong, Yingwen ;
Farwell, Wildon R. ;
Kerr, Douglas A. .
LANCET NEUROLOGY, 2013, 12 (11) :1059-1067
[9]   Predictability of disease progression in amyotrophic lateral sclerosis [J].
Czaplinski, Adam ;
Yen, Albert A. ;
Simpson, Ericka P. ;
Appel, Stanley H. .
MUSCLE & NERVE, 2006, 34 (06) :702-708
[10]  
Dias S., 2012, REPORT DECISION SUPP